188 related articles for article (PubMed ID: 36380579)
1. Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR.
Krois AS; Park S; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2022 Dec; 61(23):2709-2719. PubMed ID: 36380579
[TBL] [Abstract][Full Text] [Related]
2. Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain.
Krois AS; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11302-E11310. PubMed ID: 30420502
[TBL] [Abstract][Full Text] [Related]
3. Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.
Krois AS; Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1853-62. PubMed ID: 26976603
[TBL] [Abstract][Full Text] [Related]
4. The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations.
Fadda E; Nixon MG
Phys Chem Chem Phys; 2017 Aug; 19(32):21287-21296. PubMed ID: 28597880
[TBL] [Abstract][Full Text] [Related]
5. Domain-domain interactions in full-length p53 and a specific DNA complex probed by methyl NMR spectroscopy.
Bista M; Freund SM; Fersht AR
Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15752-6. PubMed ID: 22972749
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case.
Ithuralde RE; Turjanski AG
PLoS One; 2016; 11(1):e0144284. PubMed ID: 26742101
[TBL] [Abstract][Full Text] [Related]
7. Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain.
Wells M; Tidow H; Rutherford TJ; Markwick P; Jensen MR; Mylonas E; Svergun DI; Blackledge M; Fersht AR
Proc Natl Acad Sci U S A; 2008 Apr; 105(15):5762-7. PubMed ID: 18391200
[TBL] [Abstract][Full Text] [Related]
8. Multiple conformations of full-length p53 detected with single-molecule fluorescence resonance energy transfer.
Huang F; Rajagopalan S; Settanni G; Marsh RJ; Armoogum DA; Nicolaou N; Bain AJ; Lerner E; Haas E; Ying L; Fersht AR
Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20758-63. PubMed ID: 19933326
[TBL] [Abstract][Full Text] [Related]
9. p53 searches on DNA by rotation-uncoupled sliding at C-terminal tails and restricted hopping of core domains.
Terakawa T; Kenzaki H; Takada S
J Am Chem Soc; 2012 Sep; 134(35):14555-62. PubMed ID: 22880817
[TBL] [Abstract][Full Text] [Related]
10. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53.
Teufel DP; Freund SM; Bycroft M; Fersht AR
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7009-14. PubMed ID: 17438265
[TBL] [Abstract][Full Text] [Related]
11. 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers.
Rajagopalan S; Jaulent AM; Wells M; Veprintsev DB; Fersht AR
Nucleic Acids Res; 2008 Oct; 36(18):5983-91. PubMed ID: 18812399
[TBL] [Abstract][Full Text] [Related]
12. The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.
D'Abramo M; Bešker N; Desideri A; Levine AJ; Melino G; Chillemi G
Oncogene; 2016 Jun; 35(25):3272-81. PubMed ID: 26477317
[TBL] [Abstract][Full Text] [Related]
13. Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein.
Lee CW; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2010 Nov; 49(46):9964-71. PubMed ID: 20961098
[TBL] [Abstract][Full Text] [Related]
14. Rational design using sequence information only produces a peptide that binds to the intrinsically disordered region of p53.
Kamagata K; Mano E; Itoh Y; Wakamoto T; Kitahara R; Kanbayashi S; Takahashi H; Murata A; Kameda T
Sci Rep; 2019 Jun; 9(1):8584. PubMed ID: 31253862
[TBL] [Abstract][Full Text] [Related]
15. Modeling the relationship between the p53 C-terminal domain and its binding partners using molecular dynamics.
Allen WJ; Capelluto DG; Finkielstein CV; Bevan DR
J Phys Chem B; 2010 Oct; 114(41):13201-13. PubMed ID: 20873738
[TBL] [Abstract][Full Text] [Related]
16. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
[TBL] [Abstract][Full Text] [Related]
17. Hyperacetylation of the C-terminal domain of p53 inhibits the formation of the p53/p21 complex.
Kim U; Kim KS; Park JK; Um HD
Biochem Biophys Res Commun; 2022 Dec; 635():52-56. PubMed ID: 36257192
[TBL] [Abstract][Full Text] [Related]
18. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
[TBL] [Abstract][Full Text] [Related]
19. The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.
Laptenko O; Tong DR; Manfredi J; Prives C
Trends Biochem Sci; 2016 Dec; 41(12):1022-1034. PubMed ID: 27669647
[TBL] [Abstract][Full Text] [Related]
20. Folding and structural polymorphism of p53 C-terminal domain: One peptide with many conformations.
Kumar A; Kumar P; Kumari S; Uversky VN; Giri R
Arch Biochem Biophys; 2020 May; 684():108342. PubMed ID: 32184088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
